Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

# News

Our New Resource Page for WNT-Activated Medulloblastoma

WNT-Activated Medulloblastoma is a type of medulloblastoma, a cancerous brain tumour that starts in the cerebellum, the area of the brain that controls balance and coordination. It is most often diagnosed in older children and teenagers, although it can occur at any...

Our New Resource Page for CNS Neuroblastoma, FOXR2-Activated

CNS Neuroblastoma, FOXR2-Activated is a rare cancerous brain tumour that mainly affects children. It develops from immature nerve cells in the brain and is caused by changes that activate a gene called FOXR2, which helps the tumour grow. It usually occurs in the upper...

Our New Resource Page for EWSR1::SMAD3 Rearranged Fibroblastic Tumour

EWSR1::SMAD3 Rearranged Fibroblastic Tumour is a rare and recently recognised soft tissue tumour. It usually develops in the fingers, toes, feet, or hands. It is considered a benign (non-cancerous) tumour, but it can come back after treatment if it is not completely...

Our New Resource Page for Sclerosing Angiomatoid Nodular Transformation (SANT)

Sclerosing Angiomatoid Nodular Transformation (SANT) is a rare, non-cancerous condition that affects the spleen. It involves the formation of abnormal blood vessel nodules surrounded by fibrous tissue. Although it is benign, it can sometimes appear similar to cancer...

Our New Resource Page for CNS Tumour with BCOR/BCORL1 Fusions

CNS Tumour with BCOR/BCORL1 Fusions is a very rare and aggressive brain tumour. It develops because of abnormal changes (fusions) involving the BCOR or BCORL1 genes. This tumour is different from the more common CNS tumou with BCOR internal tandem duplication...
Older Entries
Next Entries

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter